TIGC Regional Newfoundland Symposium 2007
Translating Evidence-Based Clinical Guides into Practice
Delta Hotel, St. Johns, NL. Saturday June 9th 2007
Learning Objectives:
To describe appropriate risk factor modification with antiplatelet
therapy in the vascular patient
• To establish treatment strategies to prevent ischaemic stroke in
patients who have already had a TIA or a stroke
• To describe the family physician/ER physician's role regarding
common and rare blood disorders
• To list the risk factors for venous thromboembolism in cancer patients
• To logically select investigations for suspected DVT and PE, and
interpret test findings
• Document the evidence supporting preventative strategies in patients
with antiphospholid antibodies
"Thrombosis Interest Group of Canada (TIGC) is dedicated to furthering
education and research in the prevention and treatment of thrombosis."
|
NOTE: must be viewed using Microsoft Internet Explorer with 1024x768 monitor resolution, and Windows Media Player 9 or higher
NOTE: must be viewed using IE 5.x, Mozilla 1.2 or Safari 1.2.1 (Note: Safari 1.2.1 cannot be downloaded separately, but is only available as part of the OS X 10.3.3 update) with 1024x768 monitor resolution, and